Literature DB >> 19232643

Late-onset episodic ataxia type 2 associated with a novel loss-of-function mutation in the CACNA1A gene.

Ester Cuenca-León1, Isabel Banchs, Selma A Serra, Pilar Latorre, Noèlia Fernàndez-Castillo, Roser Corominas, Miguel A Valverde, Víctor Volpini, José M Fernández-Fernández, Alfons Macaya, Bru Cormand.   

Abstract

We report a patient with typical features of episodic ataxia type 2 (EA2) but with onset in the sixth decade and associated interictal hand dystonia. He was found to bear the novel heterozygous missense mutation p.Gly638Asp (c.1913G>A) in the CACNA1A gene. Functional analysis of the mutation on P/Q channels expressed in HEK 293 cells revealed a reduction of Ca(2+) current densities, a left-shift in the apparent reversal potential, the slowing of inactivation kinetics and the increase in the rate of current recovery from inactivation. These results are consistent with a decrease in Ca(2+) permeability through mutant P/Q channels. To our knowledge, this is just the second patient with late onset EA2 linked to a CACNA1A mutation and the first to carry a loss-of-function missense mutation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19232643     DOI: 10.1016/j.jns.2009.01.005

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  15 in total

Review 1.  Convergent mechanisms in etiologically-diverse dystonias.

Authors:  Valerie B Thompson; H A Jinnah; Ellen J Hess
Journal:  Expert Opin Ther Targets       Date:  2011-12-03       Impact factor: 6.902

2.  Late-onset episodic ataxia associated with SLC1A3 mutation.

Authors:  Kwang-Dong Choi; Joanna C Jen; Seo Young Choi; Jin-Hong Shin; Hyang-Sook Kim; Hyo-Jung Kim; Ji-Soo Kim; Jae-Hwan Choi
Journal:  J Hum Genet       Date:  2016-11-10       Impact factor: 3.172

3.  CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms.

Authors:  Lena Damaj; Alexis Lupien-Meilleur; Anne Lortie; Émilie Riou; Luis H Ospina; Louise Gagnon; Catherine Vanasse; Elsa Rossignol
Journal:  Eur J Hum Genet       Date:  2015-03-04       Impact factor: 4.246

4.  Dystonia and cerebellar degeneration in the leaner mouse mutant.

Authors:  Robert S Raike; Ellen J Hess; H A Jinnah
Journal:  Brain Res       Date:  2015-03-16       Impact factor: 3.252

5.  Reduced expression of the Ca(2+) transporter protein PMCA2 slows Ca(2+) dynamics in mouse cerebellar Purkinje neurones and alters the precision of motor coordination.

Authors:  Ruth M Empson; Paul R Turner; Raghavendra Y Nagaraja; Philip W Beesley; Thomas Knöpfel
Journal:  J Physiol       Date:  2010-01-18       Impact factor: 5.182

6.  Possible anticipation associated with a novel splice site mutation in episodic ataxia type 2.

Authors:  Kwang-Dong Choi; Ji-Won Yook; Min-Ji Kim; Hyang-Sook Kim; Young-Eun Park; Ji Soo Kim; Jae-Hwan Choi; Jin-Hong Shin; Dae-Seong Kim
Journal:  Neurol Sci       Date:  2013-01-24       Impact factor: 3.307

7.  Limited regional cerebellar dysfunction induces focal dystonia in mice.

Authors:  Robert S Raike; Carolyn E Pizoli; Catherine Weisz; Arn M J M van den Maagdenberg; H A Jinnah; Ellen J Hess
Journal:  Neurobiol Dis       Date:  2012-07-28       Impact factor: 5.996

8.  Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy.

Authors:  Sanjeev Rajakulendran; Tracey D Graves; Robyn W Labrum; Dimitrios Kotzadimitriou; Louise Eunson; Mary B Davis; Rosalyn Davies; Nicholas W Wood; Dimitri M Kullmann; Michael G Hanna; Stephanie Schorge
Journal:  J Physiol       Date:  2010-02-15       Impact factor: 5.182

Review 9.  CaV2.1 channelopathies.

Authors:  Daniela Pietrobon
Journal:  Pflugers Arch       Date:  2010-03-04       Impact factor: 3.657

Review 10.  The electrophysiological footprint of CACNA1A disorders.

Authors:  Elisabetta Indelicato; Iris Unterberger; Wolfgang Nachbauer; Andreas Eigentler; Matthias Amprosi; Fiona Zeiner; Edda Haberlandt; Manuela Kaml; Elke Gizewski; Sylvia Boesch
Journal:  J Neurol       Date:  2021-02-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.